Director equity grant at Molina Healthcare (NYSE: MOH) totals 405 shares

Q: What did Dale B. Wolf report in his latest Form 4 for MOH?

Dale B. Wolf reported receiving a grant of 405 shares of Molina Healthcare common stock. The shares were awarded as part of his director compensation under the 2025 Equity Incentive Plan and are held indirectly through his revocable trust.

Q: What is Molina Healthcare’s 2025 Equity Incentive Plan for directors?

Molina Healthcare’s 2025 Equity Incentive Plan provides stock grants to directors as part of their compensation. For Dale B. Wolf, it delivers an annual equity award valued at $220,000 , paid in four quarterly grants based on the stock’s closing price each quarter.

Q: Who holds the MOH shares reported in Dale B. Wolf’s Form 4?

The shares are held by the Dale B. Wolf Revocable Trust , where he serves as sole trustee. The Form 4 notes the 405-share grant increased the trust’s total indirect holdings to 15,396 Molina Healthcare common shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Dale B. Wolf received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with his board service. The award represents one quarterly installment of a $220,000 annual equity award, with this quarter’s $55,000 portion calculated using the April 1 closing price of $135.82 per share. Following this grant, indirect holdings for Wolf’s revocable trust increased to 15,396 shares of Molina Healthcare common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WOLF DALE B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	405	$135.82	$55K

Holdings After Transaction: Common Stock — 15,396 shares (Indirect, Held by Trust)

Footnotes (1)

Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares. Represents the closing price of the Issuer's common stock on April 1, 2026. Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Key Figures

Shares granted: 405 shares Grant price: $135.82 per share Quarterly equity value: $55,000 +2 more

5 metrics

Shares granted 405 shares Quarterly director equity award on April 1, 2026

Grant price $135.82 per share Closing price on April 1, 2026 used for grant

Quarterly equity value $55,000 One quarter of director’s annual equity award

Annual equity award $220,000 Total yearly equity compensation for each director

Total shares after grant 15,396 shares Indirect holdings in revocable trust after transaction

Key Terms

Equity Incentive Plan, annual equity award, Revocable Trust

3 terms

Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

Revocable Trust financial

"Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 04:46 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last)

(First)

(Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH

CALIFORNIA

90802

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		A⁽¹⁾		405⁽²⁾	A	$135.82⁽³⁾	15,396	I	Held by Trust⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

3. Represents the closing price of the Issuer's common stock on April 1, 2026.

4. Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Remarks:

	Jeff D. Barlow, by power of attorney for Dale B. Wolf.	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Dale B. Wolf report in his latest Form 4 for MOH?

Dale B. Wolf reported receiving a grant of 405 shares of Molina Healthcare common stock. The shares were awarded as part of his director compensation under the 2025 Equity Incentive Plan and are held indirectly through his revocable trust.

How was the size of Dale B. Wolf’s MOH stock grant determined?

The 405-share grant was based on a quarterly equity value of $55,000. This amount is one quarter of a $220,000 annual equity award, divided by Molina Healthcare’s $135.82 closing stock price on April 1, 2026.

What is Molina Healthcare’s 2025 Equity Incentive Plan for directors?

Molina Healthcare’s 2025 Equity Incentive Plan provides stock grants to directors as part of their compensation. For Dale B. Wolf, it delivers an annual equity award valued at $220,000, paid in four quarterly grants based on the stock’s closing price each quarter.

How many Molina Healthcare shares does Dale B. Wolf hold after this grant?

After the April 1, 2026 grant, Dale B. Wolf’s revocable trust holds 15,396 shares of Molina Healthcare common stock. This total reflects his indirect ownership position following receipt of the 405-share quarterly equity award.

Who holds the MOH shares reported in Dale B. Wolf’s Form 4?

The shares are held by the Dale B. Wolf Revocable Trust, where he serves as sole trustee. The Form 4 notes the 405-share grant increased the trust’s total indirect holdings to 15,396 Molina Healthcare common shares.